Background. Increasing evidence suggests the potential involvement of metalloproteinase family proteins in the pathogenesis of neuropathic pain, although the underlying mechanisms remain elusive.
Results. Results showed that the ADAM10 protein was expressed in calcitonin gene-related peptide (CGRP)-containing neurons of the dorsal root ganglia, and expression was upregulated following spinal nerve ligation surgery in vivo. Intrathecal administration of GI254023X, an ADAM10 selective inhibitor, to the rats one to three days after spinal nerve ligation surgery attenuated the spinal nerve ligation-induced mechanical allodynia and thermal hyperalgesia. Intrathecal injection of ADAM10 recombinant protein simulated pain behavior in normal rats to a similar extent as those treated by spinal nerve ligation surgery. These results raised a question about the relative contribution of ADAM10 in pain regulation. Further results showed that ADAM10 might act by cleaving E-cadherin, which is mainly expressed in satellite glial cells. GI254023X reversed spinal nerve ligation-induced downregulation of E-cadherin and activation of cyclooxygenase 2 after spinal nerve ligation. b-catenin, which creates a complex with E-cadherin in the membranes of satellite glial cells, was also downregulated by spinal nerve ligation surgery in satellite glial cells. Finally, knockdown expression of b-catenin by lentiviral infection in purified satellite glial cells increased expression of inducible nitric oxide synthase and cyclooxygenase 2.
Background
Neuropathic pain, which causes persistent nociceptive hypersensitivity [1, 2] , is a major clinical and socioeconomic problem and is experienced by patients as an innocuous stimuli-induced pain (allodynia) or as an amplification of responses to noxious stimuli [1] . Damage to peripheral nerves also often results in neuropathic pain. The establishment and maintenance of neuropathic pain could also result from inflammation in the neural system [3, 4] , specifically activation of glial cells and immune cells [3] , which induce the release of neurotransmitters, neuromediators, chemokines, and cytokines [5, 6] . These secreted molecules can form a signal network that regulates excitability of neurons, which is known as "central sensitization" [7] . Therefore, a better understanding of the molecular mechanisms of neuronal cells and peripheral glial cells with regard to the pathophysiology of neuropathic pain is necessary for the development of novel, therapeutic targets.
MMPs (matrix metalloproteinases) and ADAMs (a disintegrin and metalloproteinase) are secreted proteins that play a pivotal role in inflammation and tumor development. Distinct types of MMPs and ADAMs have diverse functions. MMPs/ADAMs have been demonstrated to control precise processes of immunity [8, 9] , tumor cell migration [10] , and angiogenesis by acting on a variety of extracellular effector proteins [11] . Several reports have shown that MMPs and ADAMS also participate in neural plasticity [12] ; ADAMs cleave extracellular matrix (ECM) protein components to form neural circuitry for the developing nervous system. Furthermore, a number of MMP family members such as MMP-2, MMP-9, and MT5-MMP have been shown to modulate pain signaling [13] .
Recently, ADAM10 was shown to be mainly expressed in neuronal cells of the central and peripheral nervous systems [11] . One of its major functions is to cleave membrane proteins such as E-cadherin during development [14, 15] . In addition, it modulates synaptogenesis during neural trauma by cleaving the cell adhesion molecule N-cadherin [16] . However, very few studies have addressed the pain-modulating function of ADAM10. The present study aimed to characterize the cellular source of ADAM10 after spinal nerve ligation (SNL) surgery and to investigate its mechanistic role in the development of neuropathic pain.
Methods

Animal Preparation
Male Sprague-Dawley rats (200-220 g) were used in these experiments in the Department of Experimental Animal Sciences, Second Military Medical University. The rats were housed with free access to food and water under a natural day/night cycle. Rats were acclimated for seven days before any experimental procedures. The environment in the vivarium was maintained at a constant temperature of 22 þ/-0. 6 C and a humidity of 60 þ/-10%. All experimental procedures were approved by the Institutional Animal Care and Use Committee at Second Military Medical University.
Spinal Nerve Ligation Model
The SNL model was performed as previously described [17] . The rats were anesthetized with 10% chloral hydrate (0.4 mL/100 g body weight, i.p.) and placed in a prone position. An incision was made to the left of the midline at the L3-S2 level. After the left L6 vertebral transverse process was removed, the left L5 spinal nerve was exposed and tightly ligated with a 6-0 silk thread. The wounds were then closed. Sham-operated rats underwent the same surgical procedure as the SNL rats, except that the left L5 spinal nerve was not ligated.
Implantation of the Intrathecal Catheter and Drug Delivery
For spinal drug delivery, all animals received an implanted intrathecal catheter at the same time as the SNL surgery. After an excision of the S1 processus spinalis, a polyethylene catheter (PE-10; 20.0 cm) was inserted into the subarachnoid space at the level of the L6-S1 vertebrae until the tip of the tube (1.5 cm) reached the lumbar cistern between the L4 and L5 vertebrae. The catheters were fixed at the lumbar region and at the back of the head. If a small dose of intrathecal lidocaine produced motor dysfunction, the catheter was considered to be successfully implanted. The applied chemicals were limited to the L4-L5 dorsal root ganglion (DRG) levels by injecting a small volume (10 ll) and by limiting the rate of the injection (3.3 ll/min) [18] . The intrathecal application of drugs was carried out one to three days after SNL surgery. The ADAM10 inhibitor, GI254023X (SML0789, Sigma), was dissolved in dimethyl sulfoxide at a final concentration of 100 mM, 50 mM, and 10 mM. The ADAM10 recombinant protein (936-AD-020, R&D, Shanghai) was dissolved in 0.1% BSA at a final concentration of 50 mM and 10 mM.
Behavioral Tests for Mechanical Thresholds
Behavioral tests were conducted before and after SNL surgery on postoperative days 1, 3, 5, 7, 14, and after drug delivery. Prior to the surgery, the rats were habituated to the testing apparatus and a baseline behavior was established. All tests were conducted by a person blinded to the treatment groups. The paw withdrawal threshold to mechanical stimuli was assessed by von Frey hairs, which were applied from underneath to the left hindpaw between the third and fourth digits (nine calibrated von Frey hairs with bending forces of 0.4-15.0 g). For each test, the rats were placed in a plastic chamber (20 Â 20 Â 25 cm) and habituated for at least 30 minutes. The chamber was placed on top of a mesh screen so that mechanical stimuli could be administered to the plantar surface of the left hindpaw.
The same set of von Frey stimuli was given in an ascending order. Each von Frey hair was repetitively tested 10 times with a two-to three-minute interval between stimuli; the bending force that evoked 50% paw withdrawal occurrence served as the mechanical threshold. If 15 g failed to evoke a withdrawal response, the value was recorded as 15 g. A decrease of 7 g in paw withdrawal mechanical threshold indicated mechanical hyperalgesia.
Behavioral Tests for Heat Hyperalgesia
Heat hyperalgesia was detected using the paw withdrawal test [19] . The rats were placed under an inverted Mechanical allodynia and thermal hyperalgesia were significantly attenuated in 100 mM group at five to seven days after SNL (*P < 0.05, † P < 0.01, compared with SNL þ Veh group, N ¼ 8 per group). C and D) ADAM10 recombinant clear plastic chamber cage (20 Â 18 Â 13 cm) on an elevated glass floor (3 mm thick). After an adaption period of 30 minutes, heat hyperalgesia was determined using a projector lamp bulb (automatic plantar analgesia tester, Institute of Biomedical Engineering, Chinese Academy of Medical Science, Tianjin, China), which provided a radiant heat source aiming through the glass onto the midplantar hindpaw. The latency of the withdrawal reflex was used as the pain threshold. An automatic cutoff of the stimulus was set at 20 seconds to avoid tissue damage. Tests were performed five times for each paw, with a five-minute interval between each test. Rats were tested for their baseline response twice before surgery. All behavioral tests were performed blinded by one person.
Cell Culture and Treatment
Culture of the purified satellite glial cells (SGCs) was performed as previously described [20] . Primary mixed neuron SGC cultures were prepared from the DRG of threeday-old Sprague-Dawley rats. Briefly, after DRG excision and enzyme dissociation at 37 C with 0.25 mg/mL trypsin, 1 mg/mL collagenase, and 0.2 mg/mL DNase (Sigma-Aldrich) was added to the cells, the cells were centrifuged, resuspended in culture medium (Ham's F-12 with 10% fetal calf serum and 1% penicillin/streptomycin), and plated onto poly-L-lysine-coated wells or glass coverslips. After replacing the media on days 1 and 3, cells were detached from the Petri dish on day 5 using a five-minute treatment with 0.5% trypsin/0.2% EDTA (Sigma-Aldrich) at 37 C, resuspended as a purified SGC culture in fresh media, and replated onto uncoated wells or 24 mm diameter coverslips. This procedure completely removed all neurons without affecting SGC adhesion and growth [21, 22] . The culture medium was replaced 24 hours later, and experiments were performed after an additional 24 hours. SGCs were infected with lentivirus-bcatenin small hairpin RNA (shRNA) or negative control (NC) virus for 12 hours and then replaced by normal medium and harvested 72 hours later.
Construction of Plasmids and shRNA
The shRNA for the Ctnnb1 gene was designed to target the sequence GCA ATC AGC TGG CCT GGT TTG, located in the last exon of the rat b-catenin transcript. DNA oligos containing the target sequence were synthesized, annealed, and inserted into the expression vector by double-digestion with HpaI and XhoI, followed by ligation with T4 DNA ligase (Shanghai GeneChem, Shanghai, China). The ligate was transformed into competent Escherichia coli DH5a cells. The correct transformant was detected by restriction enzyme analysis and DNA sequencing.
GenScript shRNA expression vector pGCL-GFP was used as a control for b-catenin shRNA, and a corresponding random shRNA sequence (TTCTCCGAACGTGTCACGT) was utilized. Then, the SGCs were transduced with lentivirus-NC-marked SGCs, or lentivirus-b-catenin shRNA-marked SGCs.
Lentivirus Production and Transduction
Lenti-b-catenin shRNA and lenti-NC virus were produced by plasmid cotransfection of 293T cells [23] . 293T cells were transfected with ViraPower packaging mix using 100 mL lipofectamine 2,000 reagent, according to the manufacturer's instructions. The viral supernatant was harvested 72 hours after transfection, passed through 0.45 mm filters, and concentrated, and the viral titer was determined. The viral supernatant was added to target SGCs at a multiplicity of infection 50 with 5 mg/mL polybrene to obtain stably transfected b-catenin knockdown (KD) cells and NC cells.
Real-Time Polymerase Chain Reaction
Total RNA from cells was isolated using an Ultraspec RNA isolation kit (Biotecx). Triplicate real-time PCR samples were obtained using TaqMan probes and the ABI Prism 7,000 sequence detection system. The following primer sequences were used: b-catenin, 5 0 -TCT GAC CAG CCG ACA TC-3 0 and 5 0 -CAC CCT GTT CCC GCA AAG-3 0 ; COX2, 5 0 -GTC TGA TGA TGT ATG CTA-3 0 and 5 0 -AA TGC GGT TCT GAT ACT GG-3 0 ; and iNOS, 5 0 -AGG CTT GGG TCT TGT TAG-3 0 and 5 0 -GT TGT TGG GCT GGG AAT AG-3 0 . Real-time polymerase chain reaction (RT-PCR) analyses were performed using an ABI 7300 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) and SYBR Green PCR kit (Applied TaKaRa, Otsu, Shiga, Japan). The DCt method was used with actin mRNA as an endogenous control for normalization of the results [24] . Data were expressed as 2 -DDCT . All DCt values were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). All RT-PCR experiments were performed at least three times, and the mean 6 SEM values are presented.
Western Blot
Rats were deeply anesthetized by 10% chloral hydrate (0.4 mL/100 g body weight, i.p.) and sacrificed by decapitation. The L5 DRGs were rapidly removed and lysed with 20 mM Tris-HCl buffer, pH 8.0, containing Figure 2 Continued proteins (50 mM) increased sensitivity to mechanical and heat stimulation induced by SNL from six to eight hours after injection (*P < 0.05, † P < 0.01, compared with SNL þ Veh group, N ¼ 7 to 10 per group). E) Western blot results indicate that GI254023X (100 mM) attenuated the downregulation of E-cadherin (SNL þ GI254023X vs SNL þ Veh: E-cadherin: 0.48 6 0.04 vs 0.28 6 0.02, N ¼ 3 per group, *P < 0.05). SNL ¼ spinal nerve ligation.
Figure 3
E-cadherin is cleaved in injured dorsal root ganglion (DRG) satellite glial cells (SGC)s after spinal nerve ligation (SNL). A) Western blot analysis showed that SNL significantly reduced full-length E-cadherin (120 kd) expression 1% NP-40, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% mercaptoethanol, 0.5 mM dithiothreitol, and a mixture of proteinase and phosphatase inhibitors (Sigma). Total proteins extracted from the SGC culture were lysed using the same methods. The protein concentration in the homogenate was determined using BCA reagent (Pierce). Protein samples (40 mg) were loaded into each lane, separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (10% polyacrylamide gels), and then electrotransferred onto nitrocellulose membranes, followed by incubation with a blocking buffer (1Â TBS with 5% wt/vol fat-free dry milk) for two hours and overnight incubation at 4 C with rabbit anti-E-cadherin (1:1,000; Abcam), rabbit anti-b-catenin (1:1,000; Abcam), rabbit anti-ADAM10 (1:1,000; Abcam), rabbit anti-iNOS (1:200; Abcam), or rabbit anti-COX2 (1:100, Abcam). The polyvinylidene fluoride membrane was then washed five times with TBST (1Â TBS and 1% Tween-20), The membranes were then incubated with alkalin-phosphatase-conjugated goat antirabbit IgG (Beyotime) diluted 1:1,000 in 2% bovine serum albumin-phosphate-buffered saline (BSA/PBS) for one hour at room temperature. The color development was performed with 400 mg/mL nitro-blue tetrazolium, 200 mg/mL 5-bromo-4-chloro-3-indolyl phosphate, and 100 mg/mL levamisole in TSM2 (0.1 mol/l Tris-HCl 2 buffer, pH 9.5, 0.1 mol/l NaCl. and 0.05 mol/l MgCl 2 ) in the dark. Bands were scanned using a densitometer (GS-700; Bio-Rad Laboratories).
Immunohistochemistry
Rats were deeply anesthetized with 10% chloral hydrate (0.4 mL/100 g body weight, i.p.) and transcardially perfused with 0.01 M PBS and 4% PFA in 0.1 M phosphate buffer (pH 7.4). The L5 DRGs were removed, postfixed at 4 C overnight, and transferred to 30% sucrose in PBS for 48 hours. L5 DRG transverse sections (15 mm thick) were prepared on gelatin-coated glass slides using a cryocut microtome. The sections were blocked in a solution containing 5% normal donkey serum (Jackson ImmunoResearch), 2% BSA (Sigma), and 0.1% Triton X-100 (Sigma) for one hour at room temperature. The sections were then incubated overnight at 4 C with a primary antibody for mouse anti-NeuN antibody 
Immunocytochemistry and Cell Identification
Primary mixed cultures and SGC purified cultures were fixed with 4% paraformaldehyde in 0.1 M phosphatebuffered saline (pH 7.4). Cells were subsequently incubated for 20 minutes at room temperature in goat serum dilution buffer (450 mM NaCl and 20 mM sodium phosphate buffer, pH 7.4, 15% goat serum, and 0.3% Triton X-100) and then transferred in the solution containing mouse antiNeuN antibody (1:2,000, Chemicon), mouse anti-S100 antibody (1:100, Abcam), or rabbit anti-E-cadherin antibody 
Statistical Analysis
Data are represented as mean 6 SEM. The statistical significance of differences was analyzed using the PASW statistical program (SPSS Inc.). Statistical analyses were performed using Student's t test and one-way analysis of variance (ANOVA). For behavior responses, a two-way ANOVA with repeated measure analyses of variance was performed followed by the Holm-Sidak post hoc test for multiple comparisons. A value of P < 0.05 was considered statistically significant.
Results
Increased Expression of ADAM10 in DRG Neurons Regulates SNL-Induced Mechanical Allodynia and Heat Hyperalgesia
To characterize the effects of ADAM10 in DRGs after SNL, we first determined the location of ADAM10 protein in DRGs and the spinal dorsal horn. ADAM10 was detected in DRG neurons ( Figure 1C ). However, following SNL surgery, ADAM10 expression was significantly increased in the injured small-size DRG neurons (diameter less than 30 lm) that express CGRP (Figure 1 , A-C).
This observation suggested that SNL may induce the expression of ADAM10 proteins from the somata of DRG neurons. To address whether increased ADAM10 expression from DRG neurons could result in allodynia, an ADAM10-selective inhibitor, GI254023X, was given to the rats through an intrathecal catheter within one to three days after SNL surgery. At three to five days after the L5 spinal nerves were ligated and following intrathecal catheter implantation, mean mechanical thresholds were greatly reduced to less than 6 g, which confirmed successful model establishment. We injected a small volume (10 ml) of GI254023X into the SNL rats using a slow infusion rate (3.3 ml/min) to limit spread of the infusate to the L4-L5 level [18] . Then, 32 rats were randomly divided into four groups of eight each. Three groups received an intrathecal injection of GI254023X at doses of 10 mM, 50 mM, or 100 mM, respectively, and one group received an equal volume of vehicle injection as the control. We then tested the withdrawal threshold for mechanical pain after intrathecal injection of GI254023X. We found that SNLinduced mechanical allodynia was significantly attenuated in the 100 mM group at five to seven days after SNL (Figure 2A ). In addition, vehicle or GI254023X treatment in sham-operated rats did not show any effect on mechanical allodynia (Figure 2A ).
We then measured thermal hyperalgesia of the SNL rats treated intrathecally with GI254023X (100 mM) or vehicle. The results suggested that GI254023X (100 mM) significantly blocked heat hyperalgesia within five to 10 days after SNL ( Figure 2B ). Sham-operated rats intrathecally injected with GI254023X (100 mM) or vehicle exhibited values not significantly different from the baseline latencies ( Figure 2B ).
In addition, we further investigated the pain-inducing effect of ADAM10. We intrathecally injected the ADAM10 recombinant protein (50 mM or 10 mM) to SNL rats at three days after surgery. As expected, ADAM10 recombinant proteins (50 mM) [25] increased sensitivity to mechanical stimulation. This pain-inducing effect was also apparent in rats when testing thermal hyperalgesia ( Figures 2C and 3D) . These results demonstrated that neural-derived ADAM10 regulated the pain threshold of mechanical allodynia and heat hyperalgesia induced by peripheral nerve injury.
GI254023X Attenuated Cleaving of E-Cadherin by ADAM10 in DRG Neurons After SNL
ADAMs cleave ECM protein components, such as adherent molecular E-cadherin [16] , consistent with the observation of E-cadherin expression in the DRG and dorsal horn. Specifically, E-cadherin was expressed in S100-labeled SGCs ( Figure 3B ) and exclusively expressed in lamina II in the spinal cord dorsal horn (Supplementary Figure 3) .
We also examined expression changes of E-cadherin in SGCs after SNL surgery in injured DRGs and the spinal dorsal horn. We observed a reduction in E-cadherin expression that was consistent with the change in pain threshold, which was significantly reduced by seven days and 14 days after surgery ( Figures 3A and 2C and Supplementary Figure 3) . Additionally, we detected the cleavage C-terminal fragments of E-cadherin (CTF) and found a slight increased expression in DRGs at three and seven days ( Figure 3A) . These results suggested that SNL surgery upregulated ADAM10 expression in DRG neurons, which was likely released from the soma of DRG neurons and synapses of unmyelinated nerve fibers to cleave E-cadherin.
We also tested E-cadherin protein expression changes after intrathecal injection of GI254023X. The results indicated that GI254023X attenuated the cleaving of E-cadherin in DRG following SNL surgery ( Figure 2E ). This attenuation was only seen in the DRG. We did not find a similar phenomenon in the spinal dorsal horn 
ADAM10 Increases COX2 Expression by Cleaving ECadherin in Vitro and in Vivo
We observed upregulated expression of E-cadherin after intrathecal injection of the ADAM10 inhibitor GI254023X. This result suggested that the effect of ADAM10 might be related to expression changes of E-cadherin. Some reports have suggested that cleavage of E-cadherin can influence the inflammatory microenvironment [26] . Therefore, we hypothesized that neuronal ADAM10 might take effect by cleaving E-cadherin in SCGs. To test this hypothesis, we established a SGC-purified culture ( Figure 4A ) and added ADAM10 recombinant proteins (final concentration of 10 mM) and GI254023X (final concentration of 5 mM) [27] , respectively, to the culture medium and detected expression levels of full-length Ecadherin and CTF of E-cadherin. We observed a downregulation of full-length E-cadherin and increased CTF of E-cadherin when treated with ADAM10 but not GI254032X, respectively. However, this effect of ADAM10 could be reversed by administration of GI254023X ( Figure 4B ), suggesting that neural-derived ADAM10 induced cleavage of E-cadherin in SGCs.
It is possible that owing to cleaving of E-cadherin, ADAM10 could influence cross-talk between neurons and SGCs. Therefore, we analyzed the expression changes of COX2, a classical molecule in the pain signaling of SGCs [7] . ADAM10 protein increased expression of COX2, and GI254023X neutralized this effect ( Figure 4B ). Additionally, COX2 expression increased after SNL surgery but decreased after intrathecal injection of the ADAM10 inhibitor GI254023X ( Figure 4C ). The abovementioned results suggested that cleavage of E-cadherin by ADAM10 initiates neural inflammatory abnormalities in the neuron-SGC microenvironment, which may be related to COX2 expression.
E-Cadherin Cleavage Induces Downregulation of b-Catenin and Subsequent Increased Inflammatory Molecular Expression
It is well known that E-cadherin forms a complex with b-catenin in the cell membrane, which is closely associated with tumor progression and inflammation [28, 29] . Therefore, to further investigate whether the cleavage of E-cadherin by ADAM10 could also induce downregulating of b-catenin expression in SGCs, we detected the location and expression changes of b-catenin in the DRG after SNL. Results showed that b-catenin colocalized in SGCs with E-cadherin and was downregulated after SNL ( Figure  5, A and B) . Then, we generated an in vitro model of purified SGC cultures, which were prepared from mixed cultures at day 5 in culture [20] . SGCs are small, spindle-shaped cells that express S100b antigen. Immunocytochemistry showed that 84% of the total number of cells were identified as SGCs (Supplementary Figure 1D) , which was sufficient for our experiments. To simulate the downregulation of b-catenin in SGCs, we used an shRNA that specifically disrupted b-catenin mRNA. Purified SGC cultures were incubated with lentivirus encoding b-catenin shRNA for 12 hours, and the cells were harvested three days later (Supplementary Figure 1, A and B) . Results showed that b-catenin shRNA specifically reduced b-catenin expression in SGCs (KD group) but had no effect on cells treated with irrelevant shRNA (NC group) ( Figure 5C ). We further investigated the function of b-catenin-specific deletion, showing increased expression of iNOS and COX2 at three days after b-catenin-specific deletion ( Figure 5 , C and D). This result suggested that reduced b-catenin in SGCs could increase expression of neuropathic pain-inducing proteins. We then hypothesized that ADAM10 inhibition in SGC culture could increase b-catenin expression. Therefore, we provided intrathecal administration of GI24023X (100 mM) to the SNL rats at day 5, resulting in significantly increased b-catenin expression in injured DRG at eight hours after drug administration ( Figure 6, A and B) . We then added GI254023X (final concentration of 5 mM) [27] to the SGC culture again and subsequently analyzed b-catenin and COX2 protein expression. Results showed that the ADAM10 inhibitor attenuated the degradation of b-catenin and downregulated COX2 expression (Supplementary Figure 2) . These results demonstrated that E-cadherin cleavage by ADAM10 may affect inflammation in SGCs by enhancing degradation of b-catenin.
Discussion
Evidence suggests that interactions between neurons and SGCs are involved in the mechanisms of chronic pain [24] . In our study, we assessed the potential involvement of ADAM10 in the DRG in terms of neuropathic pain mechanisms. Using the SNL model, we found that ligation of the L5 nerve in rats upregulated ADAM10 but gradually reduced expression of E-cadherin, which correlated with a decreased pain threshold. We also detected ADAM10 protein expression in DRG neurons, while E-cadherin was expressed in SGCs but not in neurons.
Present results showed that ADAM10 participates in pain regulation following peripheral nerve injury. This conclusion was based on the observation that intrathecal injection of the ADAM10 selective inhibitor, GI254023X, to rats one to three days after SNL surgery attenuated mechanical allodynia and heat hyperalgesia in a dose-dependent manner. Additionally, intrathecal administration of ADAM10 recombinant protein induced mechanical allodynia and heat hyperalgesia. Similarly, we found that intrathecal treatment of GI254023X increased E-cadherin expression. These results suggest that there is a pain-relieving effect due to ADAM10 inhibition, which correlated with decreased E-cadherin expression in SGCs.
SGCs, which closely surround primary sensory neurons, have been shown to modulate neuronal excitability [24] . Additionally, ADAM10 has been shown to cleave E-cadherin, a connexin protein, in the pathogenesis of tumor invasion [26] . The E-cadherin is a connexin protein; cleavage of E-cadherin may disrupt the integrity of cell junction [24] , and thus SGCs play an important role in protecting DRG neurons from macrophage infiltration.
The underlying mechanistic associated with ADAM10 that occurs in SGCs to regulate neuropathic pain remain unknown. However, it is widely accepted that SGCs participate in the generation of pain signals by releasing ATP, nerve growth factor, or proinflammatory cytokines and contribute to the development of neuronal sensitization due to their close connections with DRG neurons [7] . Recently, interference with purinergic receptors, potassium ion channels, or gap junctions in SGCs has been shown to have an analgesic effect [18, 30, 31] . Consequently, the mechanisms contained in SGCs have become a focus in the search for therapies for neuropathic pain. In our present in vitro studies, we used a purified culture of SGCs to test the influence of ADAM10 on E-cadherin cleavage. We found that ADAM10 not only increased E-cadherin cleavage, but also modulated expression of inflammatory molecular markers, such as COX2 and prostaglandin E2 release [22] . In the present study, following SNL, we analyzed expression changes of COX2 following inhibition of ADAM10 production in rats. COX2 expression was attenuated by GI254023X treatment, as well as the cleavage effect of E-cadherin. This observation suggests that E-cadherin cleavage may activate COX2 expression in the progression of neuropathic pain.
We hypothesized that E-cadherin cleavage by ADAM10 could influence downstream pain signaling in DRG. Under normal conditions, E-cadherin forms a complex with b-catenin. This complex plays a role in WNT signaling for b-catenin, which subsequently translocates to the nucleus and activates target gene transcription in association with TCF/LEF family transcription factors [28, 29] . b-catenin not only regulates myelination, but also synaptic development [32, 33] . Consistent with results showing that SNL surgery reduced b-catenin expression and activated COX2 expression in vivo, we also observed that GI254023X increased b-catenin expression and reduced COX2 expression in SGC culture. This result suggested that E-cadherin might regulate pain signaling by reducing COX2 expression via the b-catenin pathway ( Figure 6C ).
To determine whether the pain-stimulating effect of ADAM10 took place via b-catenin in SGCs, we used SGCpurified cultures infected with lentivirus b-catenin shRNA to study the loss of function of b-catenin. Specific deletion of b-catenin in SGC-purified cultures resulted in upregulated iNOS and COX2 expression. iNOS and COX2 have been shown to induce neuropathic pain in vivo, and the blocking of these molecules using neutralizing antibodies or inhibitors attenuated neuropathic pain induced by nerve injury [34, 35] . Additionally, neuron-derived NO and CGRP stimulate COX2 and iNOS expression in SGCs, which are involved in the modulation of neuronal excitability in DRG [22] . These data suggest that downregulation of b-catenin modulates pain-related molecular expression, such as COX2 and iNOS [34, 35] , in SGCs. However, further studies are needed to determine whether SGC b-catenin participates in the pathogenesis of neuropathic pain. One possibility is that downregulation of b-catenin results in inhibition of target gene transcription in association with TCF/LEF family transcription factors. Previous studies have shown that gap junctions or connexin 43 are target proteins of the Wnt/b-catenin pathway, and specific silencing of connexin 43 in SGCs of normal rats increases nociceptive behavior [30] . Conversely, studies of carcinogenesis showed that Wnt/b-catenin signaling inversely correlates with cytokineinduced iNOS overexpression and other nuclear factor-jB (NF-jB)-dependent gene expression in cancer cells. This is consistent with our SGC results. b-catenin forms a complex with NF-jB components (p65 and p50) and inhibits NF-jB transactivation, DNA binding, and target gene expression [36] . EphB receptors interact with E-cadherin and with the metalloproteinase ADAM10 at sites of adhesion, and their activation induces shedding of E-cadherin by ADAM10 at interfaces [15] . So, we could not exclude the role of the EhpB/ephrin-B signaling pathway in pain regulation.
Conclusions
Taking our in vivo and in vitro results together, we suggest that E-cadherin cleavage in SGCs by neuronalderived ADAM10 plays a role in the development of neuropathic pain after peripheral nerve injury. Loss-offunction interference of the E-cadherin/b-catenin complex in SGCs induces expression of pain-related molecules. Furthermore, intrathecal injection of an ADAM10 inhibitor increases E-cadherin expression in SGCs and reduces neuropathic pain behavior following SNL. However, further studies are needed to determine the underlying mechanisms influencing neuroinflammation in vivo.
